What we are asking for

What we are asking the Episcopal Church Medical Trust to do, starting with what it could do before January 1. Each one has been done before, by another plan or by this Church.

These requests protect parish budgets and members in treatment together. Each one has a precedent: something another plan, or this Church, has already done.

We are not giving up on coverage for weight loss. Obesity is a chronic disease, and treating it is good stewardship of the body. Request 1 protects everyone already in treatment, whatever they take these medicines for. Request 2 keeps the heart, sleep apnea and liver uses covered now. Request 4 asks for coverage to come back for 2028, in a form the plan can afford.

Now, before January 1, 2027

1. A transition for members already in treatment

Keep current users covered for six to twelve months, at a higher copay if necessary. That way people and their physicians can plan a safe next step instead of stopping on a fixed date.

People need that time: in randomized trials, people who stop these medicines regain most of the lost weight within a year. Improvements in blood pressure, blood sugar and cholesterol fade with it (evidence).

Other plans have done this. For example, when Colorado’s state employee plan ended coverage in 2025, it kept members already taking the drugs covered at a higher copay. It restored coverage for all members in May 2026 (Colorado’s FAQ). Ohio let existing approvals run until they expired (WTW comparison for Delaware’s plan).

2. Keep coverage for heart disease, sleep apnea and liver disease

The FDA has approved:

  • Wegovy to reduce the risk of heart attack, stroke and cardiovascular death in adults with established heart disease and overweight or obesity;
  • Wegovy for MASH, a serious form of fatty liver disease;
  • Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity.

These uses lose coverage too: the letter members received puts Wegovy and Zepbound themselves on the Drug Exclusion List, and only coverage for type 2 diabetes continues. We ask that these uses stay available through prior authorization.

This has been done before: when the Massachusetts state employees’ plan ended weight-loss coverage in 2026, it kept coverage for heart-risk reduction, sleep apnea and MASH (GBH News).

3. Clear, consistent answers in writing

Members are getting different answers from different sources. For example, a September CPG newsletter says Digbi Health helps members get direct-to-consumer prices, while the 2027 Enrollment Guide says only Quantum Health does. We ask for one published FAQ covering what remains covered, how late-December fills are handled, and what help is actually available.

For 2028

4. Develop and price a middle path

For 2028, bring coverage back in a form the plan can afford, instead of a blanket exclusion. Any of these would keep members in treatment at a lower cost to the plan than full coverage:

  • A member cost-share tier. Delaware’s state employee plan kept coverage in 2026 with a $200 monthly copay that does not count toward the prescription out-of-pocket maximum (Delaware’s FAQ). Its consultant projected savings of about 43 percent of what a full exclusion would save, or about 20 percent if the copay counted toward the maximum (WTW for the Delaware plan).

  • Clinical criteria with a lifestyle program. This is how the Presbyterian Church (U.S.A.) Board of Pensions still covers these drugs, using the same Express Scripts and Quantum Health partners as the Medical Trust (Board of Pensions). Evernorth, the company behind Express Scripts, offers savings guarantees for programs like this (Evernorth).

  • One preferred medicine at a negotiated price. Colorado’s state employee plan brought coverage back on May 1, 2026 with one preferred medicine. Cigna members who meet the plan’s criteria get Zepbound for a $120 copay, or another medicine if it is medically necessary (Colorado’s FAQ). Express Scripts offers a similar option within EncircleRx, the managed program the Medical Trust adopted: Zepbound as the only covered medicine, with a $200 monthly copay (Evernorth brochure). Evernorth announced the $200 limit in May 2025 and said it came “through direct negotiations” with the manufacturers (Evernorth). General Convention has already urged CPG to keep working with other churches’ plans “for achieving greater purchasing power in the provision of prescription drug benefit offerings” (Resolution 2024-A101).

  • A plan contribution toward members’ direct purchases. CPG has said its net cost after rebates is about twice the price members can get directly from the manufacturers (webinar recording, about 14:28). A fixed monthly contribution toward direct purchases, counted toward the out-of-pocket maximum, could keep people in treatment for much less. Washington University in St. Louis contributes up to $350 a month, tax-free, applied at checkout when members buy directly. Members’ own share does not count toward WashU’s out-of-pocket maximum. WashU’s prescription plan, like the Medical Trust’s, runs through Express Scripts (program page).

    Ohio’s state employee plan started a partial version in October 2025, about three months after ending coverage: a program with Virta. Members saw Virta’s clinicians, bought from the manufacturer, paid $499 up front and got $200 back four to six weeks later, as taxable income. It was limited to 2,500 employees at a time, first come, first served (Ohio’s announcement; Obesity Action Coalition). Ohio’s design shows what to avoid: paying the full price first, a taxable refund weeks later, and a first-come limit. Any contribution should be applied at checkout, tax-free and open to every eligible member. GoodRx already applies employers’ contributions toward Lilly’s employer price “at the pharmacy counter” (GoodRx).

  • An optional rider plan sponsors can choose. In 2022, General Convention said it “strongly recommends the Church Pension Group make available adequate 12-week coverage” for maternity disability. CPG offered it within about six months (Resolution 2022-C065).

CPG has said it considered a premium plan with this coverage and decided against it. It cited the difficulty of pricing the risk when only some members choose the coverage, and parity within the Church (webinar recording, about 55:50). That concern applies most to an optional rider. A member cost-share tier or a contribution toward direct purchases would apply across the whole plan.

5. Transparency and a dated review

Publish the analysis behind the decision, including:

  • how many members were affected;
  • the net savings after any change in drug-maker rebates;
  • the expected medical costs of stopping treatment;
  • whether the Medical Trust’s contract with Express Scripts limits any of the middle-path options above, and when it renews. In August 2023 the Medical Trust wrote that “Express Scripts will remain our PBM through 2026” (2024 renewal letter, posted by the Diocese of Louisiana), so a new term begins in 2027.

A contract can rule out a middle path. North Carolina’s state treasurer said the state plan’s old pharmacy contract let it cover these medicines for everyone or for no one: “There is an intermediate answer between those two extremes, but unfortunately the contract didn’t permit it.” The plan signed a new agreement in 2025 that lets it negotiate with the manufacturers directly (WUNC).

Then review the decision for 2028 with members, the CPG Client Council and plan sponsors. When the Church created the plan in 2009, Resolution 2009-A177 promised “a church-wide advisory committee that is representative of the broader church,” which would receive an annual report. In 2015, the Church Pension Fund told General Convention that this committee had become the CPG Client Council (its report). We ask that the Client Council review this decision.

At General Convention 2027

We will ask the 82nd General Convention to set a goal: that the plan cover medicines for obesity again, including for weight loss, at a cost it can sustain, from January 1, 2029. That is the earliest plan year the Convention can still affect. The proposed resolution asks the Presiding Bishop and the President of the House of Deputies to appoint five people to work with the Medical Trust toward that goal. They would see its data and work out the cost of the middle-path options above by March 31, 2028. The resolution also urges coverage now for the heart, sleep apnea and liver uses the FDA has approved, and advance notice with a transition whenever coverage ends for a treatment members are receiving. It asks for a report back. General Convention has already asked, in Resolution 2024-A101, that Medical Trust benefits be comparable to those of similar denominations, and that CPG work with its Client Council and the House of Bishops to price plans fairly across the Church. See how the Convention process works.

What we are not asking

We don’t want coverage that pushes the cost onto struggling parishes without a plan to pay for it. No one should misstate a diagnosis to get coverage, or stop treatment without their physician’s guidance.

Last updated

Back to top